Benevich Eric's Form 4 filing
Neurocrine Biosciences Inc (NBIX) · filed Feb 14, 2025
- Accession no.
- 0000914475-25-000057
- Filed
- Feb 14, 2025
- Trade date
- Feb 12-13, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 4 derivative transactions. Open-market sales total $251.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benevich EricCIK 0001643653 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +2,083 | $0.00 | $0 | 44,882 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −1,098 | $116.74 | −$128,180.52 | 43,784 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseAcquired | +1,961 | $0.00 | $0 | 45,745 | Direct | |
| Feb 13, 2025 | Common Stock | SSaleDisposed | −1,056 | $116.71 | −$123,245.76 | 44,689 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +42,805 | $0.00 | $0 | 42,805 | Direct | |
| Feb 12, 2025 | Common Stock | AGrant or awardAcquired | +8,022 | $0.00 | $0 | 8,022 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −2,083 | $0.00 | $0 | 4,166 | Direct | |
| Feb 13, 2025 | Common Stock | MOption exerciseDisposed | −1,961 | $0.00 | $0 | 5,885 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.